EMA fast-tracks treatment of multiple myeloma for approval in EU

View source ↗

Summary

EMA expedites evaluation of a multiple myeloma treatment for potential approval in the European Union.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma